• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Medical Device Market
    Medical Device News
    Medical Device Stocks
    • Medical Device Market
    • Medical Device News
    • Medical Device Stocks
    medical device investing

    TSO3 Reveals Voting Results from Shareholder Meeting

    Bryan Mc Govern
    May. 11, 2017 09:44AM PST
    Medical Device Investing

    TSO3 (TSX:TOS) announced the breakdown of votes from its most recent annual shareholder meeting.

    TSO3 (TSX:TOS) announced the breakdown of votes from its most recent annual shareholder meeting.
    As quoted in the press release:

    [The company] announced that the nominees listed in the management proxy circular dated April 4, 2017, were elected as directors of TSO3. In addition, all other proposals submitted by management were approved.
    Election of Directors
    Based on the proxies received and the votes on a show of hands, the following individuals were elected as directors of the Corporation until the next annual shareholders’ meeting. Accordingly, the results are set out below:
     

    Name

    Votes for

    % for

    Votes
    against

    %
    against

    Withheld

    % withheld

    Germain Carrière

    31,583,349

    86.21

    0

    0

    5,053,411

    13.79

    Pierre Désy

    36,616,660

    99.95

    0

    0

    20,100

    0.05

    Jean Lamarre

    36,602,792

    99.91

    0

    0

    33,968

    0.09

    Claude Michaud

    36,605,792

    99.92

    0

    0

    30,968

    0.08

    Jeffrey Pompeo

    36,594,567

    99.88

    0

    0

    42,193

    0.12

    Jean-Pierre Robert

    36,605,192

    99.91

    0

    0

    31,568

    0.09

    Linda Rosentstock

    36,591,224

    99.88

    0

    0

    45,536

    0.12

    Richard M. Rumble

    36,604,067

    99.91

    0

    0

    32,693

    0.09

    Steve West

    36,597,424

    99.89

    0

    0

    39,336

    0.11

    Click here to read the full press release.

    Source: www.newswire.ca

    medical device investing
    The Conversation (0)

    Go Deeper

    AI Powered

    Sherritt Reports Q1 Results and Successful Implementation of the Cobalt Swap

    UEX Corporation Reports Results of Annual General Shareholder Meeting

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Medical Device Investing Stocks

    Cleo Diagnostics

    Cleo Diagnostics (COV:AU)
    COV:AU

    Applied UV

    Applied UV (AUVI:NSD)
    AUVI:NSD

    Avricore Health

    Avricore Health (AVCR:CC)
    AVCR:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES